↓ Skip to main content

Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema

Overview of attention for article published in Cochrane database of systematic reviews, December 2012
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (56th percentile)

Mentioned by

twitter
3 tweeters
f1000
1 research highlight platform

Citations

dimensions_citation
58 Dimensions

Readers on

mendeley
97 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema
Published in
Cochrane database of systematic reviews, December 2012
DOI 10.1002/14651858.cd007419.pub3
Pubmed ID
Authors

Virgili G, Parravano M, Menchini F, Brunetti M, Gianni Virgili, Mariacristina Parravano, Francesca Menchini, Massimo Brunetti, Virgili, Gianni, Parravano, Mariacristina, Menchini, Francesca, Brunetti, Massimo

Abstract

Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Although grid or focal laser photocoagulation has been shown to reduce the risk of visual loss in DMO or clinically significant macular oedema (CSMO), vision is rarely improved. Antiangiogenic therapy with anti-vascular endothelial growth factor (anti-VEGF) modalities has recently been proposed for improving vision in people with DMO.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 2%
Ecuador 2 2%
Canada 1 1%
Brazil 1 1%
Austria 1 1%
Singapore 1 1%
China 1 1%
Spain 1 1%
United States 1 1%
Other 0 0%
Unknown 86 89%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 20%
Researcher 15 15%
Student > Bachelor 14 14%
Student > Ph. D. Student 13 13%
Student > Postgraduate 10 10%
Other 19 20%
Unknown 7 7%
Readers by discipline Count As %
Medicine and Dentistry 56 58%
Agricultural and Biological Sciences 9 9%
Biochemistry, Genetics and Molecular Biology 5 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Economics, Econometrics and Finance 2 2%
Other 10 10%
Unknown 12 12%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2013.
All research outputs
#6,531,377
of 12,100,779 outputs
Outputs from Cochrane database of systematic reviews
#5,285
of 7,978 outputs
Outputs of similar age
#120,811
of 288,175 outputs
Outputs of similar age from Cochrane database of systematic reviews
#267
of 374 outputs
Altmetric has tracked 12,100,779 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,978 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.6. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 288,175 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.
We're also able to compare this research output to 374 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.